← Back to search

THERAVANCE BIOPHARMA, INC.

TBPH · NASDAQ

Pharmaceutical Preparation Manufacturing

Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its research is focused in the areas of inflammation and immunology.

ESG Scores

Overall ESG
5.1
Environmental
3.0
Social
2.5
Governance
6.8

Gender Diversity

Female Directors0.375%
CEO GenderMale

Market Data

Price$17.23+0.45 (+2.68%)
Market Cap$887M
P/E Ratio8.38
EPS$—
52W High$21.03
52W Low$8.33
Beta0.21